首页> 外文期刊>Clinical and vaccine immunology: CVI >Competitive Electrochemiluminescence Wash and No-Wash Immunoassays for Detection of Serum Antibodies to Smooth Brucella Strains
【24h】

Competitive Electrochemiluminescence Wash and No-Wash Immunoassays for Detection of Serum Antibodies to Smooth Brucella Strains

机译:竞争性电化学发光洗涤和无洗免疫分析法检测平滑布鲁氏菌菌株的血清抗体

获取原文
           

摘要

Brucellosis is a bacterial zoonotic disease of major global importance. Natural hosts for Brucella species include animals of economic significance, such as cattle and small ruminants. Controlling brucellosis in natural hosts by high-throughput serological testing followed by the slaughter of seropositive animals helps to prevent disease transmission. This study aimed to convert an existing competitive enzyme-linked immunosorbent assay (cELISA), used for the serodiagnosis of brucellosis in ruminants, to two electrochemiluminescence (ECL) immunoassays on the Meso Scale Discovery (MSD) platform. The first assay employed a conventional plate washing step as part of the protocol. The second was a no-wash assay, made possible by the proximity-based nature of ECL signal generation by the MSD platform. Both ECL wash and no-wash assays closely matched the parent cELISA for diagnostic sensitivity and specificity. The results also demonstrated that both ECL assays met World Organization for Animal Health (OIE) standards, as defined by results for the OIE standard serum (OIEELISASPSS). This report is the first to describe an ECL assay incorporating lipopolysaccharide, an ECL assay for serodiagnosis of a bacterial infectious disease, a separation-free (no-wash) ECL assay for the detection of serum antibodies, and the use of the MSD platform for serodiagnosis. The simple conversion of the cELISA to the MSD platform suggests that many other serodiagnostic tests could readily be converted. Furthermore, the alignment of these results with the multiplex capability of the MSD platform offers the potential of no-wash multiplex assays to screen for several diseases.
机译:布鲁氏菌病是一种具有全球重要性的细菌性人畜共患病。 Brucella 物种的天然宿主包括具有经济意义的动物,例如牛和小反刍动物。通过高通量血清学检测控制屠宰自然宿主,然后屠杀血清阳性动物有助于预防疾病的传播。这项研究的目的是将用于反刍动物布鲁氏菌病血清学诊断的现有竞争性酶联免疫吸附测定(cELISA)转换为在Meso Scale Discovery(MSD)平台上进行的两种电化学发光(ECL)免疫测定。第一次测定采用常规的板洗涤步骤作为方案的一部分。第二种是免洗分析,这是通过MSD平台生成ECL信号的基于接近度的特性而实现的。 ECL洗涤法和不洗涤法均与母体cELISA紧密匹配,可用于诊断敏感性和特异性。结果还表明,两种ECL分析均符合世界动物卫生组织(OIE)标准,这是根据OIE标准血清(OIEELISA SP SS)的结果定义的。该报告首次描述了结合了脂多糖的ECL测定,用于细菌感染性疾病的血清诊断的ECL测定,用于血清抗体检测的无分离(免清洗)ECL测定以及MSD平台用于血清学诊断。从cELISA到MSD平台的简单转换表明,许多其他的血清学诊断测试都可以轻松转换。此外,将这些结果与MSD平台的多重分析能力进行比对,可提供免洗多重分析筛查多种疾病的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号